0001127602-24-015082.txt : 20240513 0001127602-24-015082.hdr.sgml : 20240513 20240513160348 ACCESSION NUMBER: 0001127602-24-015082 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240513 FILED AS OF DATE: 20240513 DATE AS OF CHANGE: 20240513 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SOBECKI CHRISTOPHER J CENTRAL INDEX KEY: 0001053892 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30111 FILM NUMBER: 24938931 MAIL ADDRESS: STREET 1: C/O WW INTERNATIONAL STREET 2: 675 AVENUE OF THE AMERICAS, 6TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10010 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LEXICON PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001062822 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 760474169 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2445 TECHNOLOGY FOREST BLVD. STREET 2: SUITE 1100 CITY: THE WOODLANDS STATE: TX ZIP: 77381 BUSINESS PHONE: 2818633000 MAIL ADDRESS: STREET 1: 2445 TECHNOLOGY FOREST BLVD. STREET 2: SUITE 1100 CITY: THE WOODLANDS STATE: TX ZIP: 77381 FORMER COMPANY: FORMER CONFORMED NAME: LEXICON PHARMACEUTICALS, INC./DE DATE OF NAME CHANGE: 20070426 FORMER COMPANY: FORMER CONFORMED NAME: LEXICON GENETICS INC/TX DATE OF NAME CHANGE: 20000126 4 1 form4.xml PRIMARY DOCUMENT X0508 4 2024-05-13 0001062822 LEXICON PHARMACEUTICALS, INC. LXRX 0001053892 SOBECKI CHRISTOPHER J 2445 TECHNOLOGY FOREST BLVD. 11TH FLOOR THE WOODLANDS TX 77381 1 0 Stock Option (Right to Buy) 1.79 2024-05-13 4 A 0 44906 0 A 2034-05-13 Common Stock 44906 44906 D Restricted Stock Units 0 2024-05-13 4 A 0 36810 0 A Common Stock 36810 36810 D Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date. Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. Each restricted stock unit represents a contingent right to receive one share of common stock. /s/ Christopher J. Sobecki 2024-05-13